Blume Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.56M | Sell |
44,074
-285
| -0.6% | -$25.4K | 0.67% | 47 |
|
|
2026
Q1 | $3.19M | Buy |
44,359
+285
| +0.6% | +$22K | 0.54% | 53 |
|
|
2025
Q4 | $3.5M | Sell |
44,074
-6,645
| -13% | -$524K | 0.64% | 46 |
|
|
2025
Q3 | $3.82M | Sell |
50,719
-50
| -0.1% | -$3.43K | 0.73% | 42 |
|
|
2025
Q2 | $3.5M | Sell |
50,769
-16,865
| -25% | -$1.11M | 0.7% | 46 |
|
|
2025
Q1 | $4.58M | Sell |
67,634
-475
| -0.7% | -$28.4K | 1.03% | 39 |
|
|
2024
Q4 | $3.06M | Sell |
68,109
-73,448
| -52% | -$4.12M | 0.68% | 48 |
|
|
2024
Q3 | $8.9M | Buy |
141,557
+7,855
| +6% | +$458K | 1.99% | 21 |
|
|
2024
Q2 | $7.9M | Buy |
133,702
+30,047
| +29% | +$1.88M | 1.9% | 23 |
|
|
2024
Q1 | $8.27M | Buy |
103,655
+11,896
| +13% | +$909K | 2% | 23 |
|
|
2023
Q4 | $7.25M | Buy |
91,759
+5,250
| +6% | +$374K | 1.89% | 19 |
|
|
2023
Q3 | $6.04M | Buy |
86,509
+106
| +0.1% | +$7.51K | 1.79% | 22 |
|
|
2023
Q2 | $5.97M | Buy |
86,403
+16,839
| +24% | +$1.2M | 1.75% | 24 |
|
|
2023
Q1 | $5.17M | Buy |
69,564
+29,668
| +74% | +$2.49M | 1.64% | 23 |
|
|
2022
Q4 | $3.72M | Sell |
39,896
-2,160
| -5% | -$208K | 1.26% | 32 |
|
|
2022
Q3 | $4.01M | Sell |
42,056
-2,860
| -6% | -$283K | 1.51% | 26 |
|
|
2022
Q2 | $4.16M | Sell |
44,916
-31,955
| -42% | -$3.12M | 1.64% | 25 |
|
|
2022
Q1 | $7.78M | Sell |
76,871
-25,014
| -25% | -$2.63M | 2.57% | 14 |
|
|
2021
Q4 | $10.5M | Sell |
101,885
-3,085
| -3% | -$285K | 3.47% | 6 |
|
|
2021
Q3 | $8.91M | Buy |
104,970
+1,440
| +1% | +$121K | 3.26% | 12 |
|
|
2021
Q2 | $8.64M | Sell |
103,530
-10,857
| -9% | -$889K | 3.16% | 12 |
|
|
2021
Q1 | $8.61M | Buy |
114,387
+5,338
| +5% | +$389K | 3.39% | 11 |
|
|
2020
Q4 | $7.45M | Buy |
109,049
+1,784
| +2% | +$116K | 3.19% | 13 |
|
|
2020
Q3 | $6.26M | Buy |
107,265
+1,962
| +2% | +$122K | 3.18% | 11 |
|
|
2020
Q2 | $6.84M | Hold |
105,303
| – | – | 3.79% | 8 |
|
|
2020
Q1 | $6.25M | Buy |
105,303
+5,450
| +5% | +$364K | 4% | 7 |
|
|
2019
Q4 | $7.42M | Sell |
99,853
-6,075
| -6% | -$427K | 3.63% | 7 |
|
|
2019
Q3 | $6.68M | Buy |
105,928
+250
| +0.2% | +$14.8K | 3.34% | 8 |
|
|
2019
Q2 | $5.76M | Buy |
105,678
+13,663
| +15% | +$736K | 2.92% | 11 |
|
|
2019
Q1 | $4.96M | Buy |
92,015
+21,645
| +31% | +$1.34M | 2.61% | 14 |
|
|
2018
Q4 | $4.61M | Buy |
70,370
+19,700
| +39% | +$1.47M | 2.63% | 12 |
|
|
2018
Q3 | $3.99M | Buy |
50,670
+4,625
| +10% | +$331K | 2.08% | 17 |
|
|
2018
Q2 | $2.96M | Buy |
+46,045
| New | +$3.03M | 1.62% | 26 |
|
Other funds holding CVS
CF
HCM
Blume Capital Management's CVS Position: Q2 2026 in Review
Blume Capital Management reduced its CVS Health (CVS) stake by 0.64% in Q2 2026, selling an estimated $25.4K and leaving 44,074 shares worth $4.56M. The position accounts for 0.67% of the portfolio, ranked #47.
Blume Capital Management first reported a position in CVS in Q2 2018 and has held it in 33 quarters since. The position peaked at $10.5M in Q4 2021. 924 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Blume Capital Management held 44,074 shares of CVS Health worth $4.56M as of Q2 2026.
- Blume Capital Management sold 285 CVS Health shares in Q2 2026, an estimated $25.4K.
- CVS Health made up 0.67% of Blume Capital Management's portfolio in Q2 2026, its #47 holding.
- Blume Capital Management first reported a position in CVS Health in Q2 2018 and has held it in 33 quarters since.
- Blume Capital Management's CVS Health position peaked at $10.5M in Q4 2021.
- 924 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.